Assisted Reproduction Technology Treatment Outcomes in Female Carriers of 21-Hydroxylase Deficiency

Medical Journal
Written by Abby Hunt

Arcaz AC, Hernandez-Nieto C, Lee JA, Cacchione TA, Mukherjee T, Copperman AB. Assisted Reproduction Technology Treatment Outcomes in Female Carriers of 21-Hydroxylase Deficiency. J Clin Endocrinol Metab. 2025 Apr 2:dgaf198. doi: 10.1210/clinem/dgaf198. Epub ahead of print. PMID: 40171917.

Abby Hunt
Previous

In vitro fertilization with cryopreserved oocytes or embryos after cancer: The role of gestational carriers
Next

Dietary advanced glycation end products (AGEs) and superovulation with gonadotropins alter RAGE expression in the ovaries differently at each follicular stage of development